Overall, genetic variants in components of the PI3K pathway can either enhance or impair its signalling capacity, highlighting the need for functional evaluation upon identification of a new variant in a patient with immunodeficiency. The gene discussed is PIK3CG; the disease is immunodeficiency disease.